Fig. 11From: Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reactionPreliminary safety evaluation of OXA@Fn in mice. A H&E staining of brain, heart, liver, spleen, lung and kidney tissue in mice. B, C Effects of OXA@Fn on ALT and AST activity in serum of mice. D, E Effects of OXA@Fn on content of BUN and CREA in serum of mice. The green area indicates the normal ranges. (n = 3, mean ± SD)Back to article page